EDITAS MEDICINE, INC. Earnings Per Share, Basic and Diluted
EDITAS MEDICINE, INC. (EDIT) reported Earnings Per Share, Basic and Diluted of -$0.81 per share for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-08-05
- EDITAS MEDICINE, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.81.
- EDITAS MEDICINE, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.86.
- EDITAS MEDICINE, INC. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.43.
- EDITAS MEDICINE, INC. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.69.
- EDITAS MEDICINE, INC. earnings per share, basic and diluted for fiscal 2020 was -$1.98.
- EDITAS MEDICINE, INC. earnings per share, basic and diluted for fiscal 2019 was -$2.68.
- EDITAS MEDICINE, INC. earnings per share, basic and diluted for fiscal 2018 was -$2.33.
- EDITAS MEDICINE, INC. earnings per share, basic and diluted for fiscal 2017 was -$2.98.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-06-30 | -$0.81 10-Q · filed 2021-08-05 | -$1.67 10-Q · filed 2021-08-05 | ||
| 2021-03-31 | -$0.86 10-Q · filed 2021-05-06 | |||
| 2020-12-31 | -$1.98 10-K · filed 2021-02-26 | |||
| 2020-06-30 | -$0.43 10-Q · filed 2021-08-05 | -$1.12 10-Q · filed 2021-08-05 | -$1.83 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$2.49 derived: net income ÷ weighted average shares · filed 2021-02-26 |
| 2020-03-31 | -$0.69 10-Q · filed 2021-05-06 | -$1.41 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$2.08 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$2.77 derived: net income ÷ weighted average shares · filed 2021-02-26 |
| 2019-12-31 | -$0.72 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$1.39 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$2.07 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$2.68 10-K · filed 2021-02-26 |
| 2019-09-30 | -$0.66 10-Q · filed 2019-11-12 | -$1.35 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$1.95 10-Q · filed 2019-11-12 | -$2.47 derived: net income ÷ weighted average shares · filed 2021-02-26 |
| 2019-06-30 | -$0.69 10-Q · filed 2020-08-07 | -$1.29 10-Q · filed 2020-08-07 | -$1.81 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$2.14 derived: net income ÷ weighted average shares · filed 2021-02-26 |
| 2019-03-31 | -$0.60 10-Q · filed 2020-05-08 | -$1.12 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$1.45 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$2.26 derived: net income ÷ weighted average shares · filed 2021-02-26 |
| 2018-12-31 | -$0.52 10-K · filed 2019-03-01 | -$0.84 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$1.66 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$2.33 10-K · filed 2021-02-26 |
| 2018-09-30 | -$0.32 10-Q · filed 2019-11-12 | -$1.14 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$1.81 10-Q · filed 2019-11-12 | -$2.65 derived: net income ÷ weighted average shares · filed 2020-02-26 |
| 2018-06-30 | -$0.82 10-Q · filed 2019-08-07 | -$1.50 10-Q · filed 2019-08-07 | -$2.34 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$3.00 derived: net income ÷ weighted average shares · filed 2020-02-26 |
| 2018-03-31 | -$0.67 10-Q · filed 2019-05-08 | -$1.52 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$2.16 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$2.82 derived: net income ÷ weighted average shares · filed 2020-02-26 |
| 2017-12-31 | -$0.85 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$1.50 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$2.15 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$2.98 10-K · filed 2020-02-26 |
| 2017-09-30 | -$0.64 10-Q · filed 2018-11-08 | -$1.29 derived: net income ÷ weighted average shares · filed 2019-03-01 | -$2.13 10-Q · filed 2018-11-08 | -$3.20 derived: net income ÷ weighted average shares · filed 2019-03-01 |
| 2017-06-30 | -$0.65 10-Q · filed 2018-08-07 | -$1.49 10-Q · filed 2018-08-07 | -$2.57 derived: net income ÷ weighted average shares · filed 2019-03-01 | -$3.17 derived: net income ÷ weighted average shares · filed 2019-03-01 |
| 2017-03-31 | -$0.85 10-Q · filed 2018-05-04 | -$1.95 derived: net income ÷ weighted average shares · filed 2019-03-01 | -$2.55 derived: net income ÷ weighted average shares · filed 2019-03-01 | -$3.09 derived: net income ÷ weighted average shares · filed 2019-03-01 |
| 2016-12-31 | -$1.10 derived: net income ÷ weighted average shares · filed 2019-03-01 | -$1.70 derived: net income ÷ weighted average shares · filed 2019-03-01 | -$2.24 derived: net income ÷ weighted average shares · filed 2019-03-01 | -$3.02 10-K · filed 2019-03-01 |
| 2016-09-30 | -$0.59 10-Q · filed 2017-11-08 | -$1.13 derived: net income ÷ weighted average shares · filed 2018-03-08 | -$1.86 10-Q · filed 2017-11-08 | -$2.93 derived: net income ÷ weighted average shares · filed 2018-03-08 |
| 2016-06-30 | -$0.54 10-Q · filed 2017-08-09 | -$1.28 10-Q · filed 2017-08-09 | -$2.45 derived: net income ÷ weighted average shares · filed 2018-03-08 | -$3.59 derived: net income ÷ weighted average shares · filed 2018-03-08 |
| 2016-03-31 | -$0.80 10-Q · filed 2017-05-15 | -$2.40 derived: net income ÷ weighted average shares · filed 2018-03-08 | -$4.02 derived: net income ÷ weighted average shares · filed 2018-03-08 | -$11.21 derived: net income ÷ weighted average shares · filed 2018-03-08 |
| 2015-12-31 | -$4.04 derived: net income ÷ weighted average shares · filed 2018-03-08 | -$6.66 derived: net income ÷ weighted average shares · filed 2018-03-08 | -$24.55 derived: net income ÷ weighted average shares · filed 2018-03-08 | -$28.55 10-K · filed 2018-03-08 |
| 2015-09-30 | -$2.57 10-Q · filed 2016-11-09 | -$21.44 derived: net income ÷ weighted average shares · filed 2017-03-03 | -$25.53 10-Q · filed 2016-11-09 | |
| 2015-06-30 | -$21.45 10-Q · filed 2016-08-10 | -$25.38 10-Q · filed 2016-08-10 | ||
| 2015-03-31 | -$2.75 10-Q · filed 2016-05-13 | |||
| 2014-12-31 | -$12.46 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |